STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CTSO CYTOSORBENTS CORPORATION StockScouter® Report

5

StockScouter® Score

CYTOSORBENTS CORPORATION, a micro cap value company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but is not suggestive of future returns. Neutral

 

Concerns

  • Moving average analysis for CTSO suggests weak price movement over the medium term. Negative
  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

D
C
C
C

Previous Ratings

6
6
7